During its third track, BioFIT 2016 will address the major challenges which are shaping innovation funding for life sciences, including:

  • A case study of funding models for new ventures
  • Dos and don’ts from experienced entrepreneurs
  • A focus on the European seed capital market
  • Tips and tricks from VC’s about Series A financing

This stimulating track will focus on transmitting knowledge and optimizing key experts’ skills and experience.

Discover the Track 3 speakers:

  • Thierry Laugel, Managing Partner and chairman of the Management Board of Kurma Partners, FR
  • Philippe Monteyne, VC partner, Fund+, NL
  • Michèle Ollier, Co-founder and partner, Medicxi Ventures, CH,
  • Sam Fazeli, Head of Bloomberg Intelligence, EMEA; Senior Pharmaceutical Analyst – ‎Bloomberg, UK,
  • Jasper Bos, Vice President and Head of Healthcare, Merck Ventures, CH
  • Daniel Green, CEO, Yaqrit, UK,
  • Charles Woler, CEO of Biomnis, FR